entity

SCFAS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SCFAS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

23Connections

4Hypotheses

3Analyses

21Outgoing

2Incoming

0Experiments

3Debates

No AI portrait yet

Outgoing (21)

Target	Relation	Type	Str
FFAR2	activates	protein	0.90
FFAR3	activates	protein	0.90
FFAR3	activates	protein	0.90
FFAR2	activates	protein	0.90
alpha-synuclein aggregation	inhibits	process	0.80
neuroinflammation	inhibits	process	0.80
alpha-synuclein burden	regulates	phenotype	0.70
gut-to-brain propagation	regulates	phenotype	0.70
NLRP3 Inflammasome	regulates	gene	0.70
neuronal stress resistance	enhances	phenotype	0.70
PROTEOSTASIS	regulates	phenotype	0.70
parkinson-disease	decreases_risk	disease	0.70
synucleinopathy	regulates	disease	0.70
Neuroinflammation	modulates	process	0.70
neuroinflammation	modulates	mechanism	0.70
alpha-synuclein burden	reduces	phenotype	0.70
GLP1R agonism	associated_with	therapy	0.70
FFAR3/GPR41	activates	protein	0.70
FFAR2/GPR43	activates	protein	0.70
NLRP3 inflammasome	modulates	protein	0.70
proteostasis	modulates	process	0.50

Incoming (2)

Source	Relation	Type	Str
38565643	regulate	paper	0.90
38565643	have been implicated in	paper	0.60

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Physiological SCFAs may confer indirect anti-synuclein benef	0.670	neurodegeneration	Do physiological concentrations of SCFAs
Physiological SCFAs may reduce alpha-synuclein burden primar	0.650	neurodegeneration	Do physiological concentrations of SCFAs
The most realistic translational use of physiological SCFAs	0.610	neurodegeneration	Do physiological concentrations of SCFAs
Physiological SCFAs may worsen alpha-synuclein pathology thr	0.550	neurodegeneration	Do physiological concentrations of SCFAs